ALPHAMAB-B (09966) repurchased 350,000 shares at a cost of HK$3.4198 million on November 17th.
Kangning Jeri Pharmaceutical - B (09966) announced on November 17, 2025, an expenditure of 3.4198 million...
ALPHAMAB-B(09966) announces the repurchase of 350,000 shares at a cost of HK$3.4198 million on November 17, 2025.
Related Articles
Subsidiary of Shenzhen New Nanshan Holding (002314.SZ) plans to participate in the investment in the infrastructure sector of the Merchants Bay and Shenzhen Heavy Industries (Foshan).
IDT INT'L (00167) received a discount of approximately 68.90% and resumed trading on November 18th.
Chaozhou Three-Circle (Group) has appointed Ernst & Young in Hong Kong as the audit firm for the H-share issue and listing.
Subsidiary of Shenzhen New Nanshan Holding (002314.SZ) plans to participate in the investment in the infrastructure sector of the Merchants Bay and Shenzhen Heavy Industries (Foshan).
IDT INT'L (00167) received a discount of approximately 68.90% and resumed trading on November 18th.
Chaozhou Three-Circle (Group) has appointed Ernst & Young in Hong Kong as the audit firm for the H-share issue and listing.
RECOMMEND
Energy Storage Industry Set To Ride the AI Tailwind; UBS: Global Demand May Surge 40% Next Year
13/11/2025
Double Eleven’s Cooling To A Historic Low? A Necessary Step Toward E‑commerce Maturity
13/11/2025
On The Eve of L3 Mass Commercialization: How Autonomous Driving Will Reconfigure a Trillion‑Yuan Service Market
13/11/2025
